Literature DB >> 19931138

The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.

I Khalil1, M A Brewer, T Neyarapally, C D Runowicz.   

Abstract

Ovarian cancer is one of the most common gynecologic malignancies and is the 5th leading cause of cancer mortality in women in the United States. Understanding the biology and molecular pathogenesis of ovarian epithelial tumors is key to developing improved prognostic indicators and effective therapies. The selection of ovarian serous carcinomas as one of the three cancer types for extensive genomic and proteomic characterization of The Cancer Genome Atlas (TCGA) project offers an important opportunity to extend our knowledge of ovarian cancer. The data portal includes molecular characterization, high throughput sequencing, and clinical data. Models to determine which of these genes act as "key drivers" of ovarian carcinogenesis and which are innocent "passengers" are needed. Standard statistical approaches often fail to differentiate between these driver and passenger genes, given that the correlation between sets of genes or genes and endpoints alone does not establish causality. As contrasted to basic correlations analyses, biological network models offer the ability to resolve causality by elucidating the directional linkages between genetics, molecular characterizations of the system, and clinical measures. This article describes the use of a novel, supercomputer-driven approach named REFS to learn network models directly from the TGCA ovarian cancer data set and simulate these models to learn the "key drivers" of ovarian carcinogenesis. The model can be validated by out-of-sample testing, and may provide a powerful new tool for ovarian cancer research. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 19931138     DOI: 10.1016/j.ygyno.2009.10.085

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.

Authors:  Rémi Longuespée; Charlotte Boyon; Céline Castellier; Amélie Jacquet; Annie Desmons; Olivier Kerdraon; Denis Vinatier; Isabelle Fournier; Robert Day; Michel Salzet
Journal:  Histochem Cell Biol       Date:  2012-04-25       Impact factor: 4.304

2.  Systems proteomics for translational network medicine.

Authors:  D Kent Arrell; Andre Terzic
Journal:  Circ Cardiovasc Genet       Date:  2012-08-01

3.  Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.

Authors:  Alison M Karst; Keren Levanon; Ronny Drapkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

4.  Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models.

Authors:  Cai M Roberts; Sophia Allaf Shahin; Wei Wen; James B Finlay; Juyao Dong; Ruining Wang; Thanh H Dellinger; Jeffrey I Zink; Fuyuhiko Tamanoi; Carlotta A Glackin
Journal:  Nanomedicine       Date:  2016-11-25       Impact factor: 5.307

5.  EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Authors:  Alexandria M Haslehurst; Madhuri Koti; Moyez Dharsee; Paulo Nuin; Ken Evans; Joseph Geraci; Timothy Childs; Jian Chen; Jieran Li; Johanne Weberpals; Scott Davey; Jeremy Squire; Paul C Park; Harriet Feilotter
Journal:  BMC Cancer       Date:  2012-03-19       Impact factor: 4.430

6.  TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.

Authors:  Cai M Roberts; Michelle A Tran; Mary C Pitruzzello; Wei Wen; Joana Loeza; Thanh H Dellinger; Gil Mor; Carlotta A Glackin
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

7.  Histotype-specific copy-number alterations in ovarian cancer.

Authors:  Ruby Yunju Huang; Geng Bo Chen; Noriomi Matsumura; Hung-Cheng Lai; Seiichi Mori; Jingjing Li; Meng Kang Wong; Ikuo Konishi; Jean-Paul Thiery; Liang Goh
Journal:  BMC Med Genomics       Date:  2012-10-18       Impact factor: 3.063

8.  Discovery of Emphysema Relevant Molecular Networks from an A/J Mouse Inhalation Study Using Reverse Engineering and Forward Simulation (REFS™).

Authors:  Yang Xiang; Ulrike Kogel; Stephan Gebel; Michael J Peck; Manuel C Peitsch; Viatcheslav R Akmaev; Julia Hoeng
Journal:  Gene Regul Syst Bio       Date:  2014-02-19

9.  The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.

Authors:  Yubin Mao; Jinfei Xu; Zhihan Li; Nini Zhang; Hao Yin; Zuguo Liu
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.